Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | MRNA | BMY | AMGN | GILD |
| Company | Halozyme Therapeutic | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 37.73 | 102.37 | 48.21 | 264.63 | 66.25 |
| High | 38.01 | 103.75 | 48.39 | 264.63 | 66.46 |
| Low | 37.73 | 102.09 | 48.15 | 260.75 | 66.17 |
| Last | 38.17 | 103.04 | 48.31 | 263.58 | 66.50 |
| Change | +0.36 | +1.04 | +0.01 | +0.83 | +0.34 |
| % Change | +0.95% | +1.02% | +0.02% | +0.32% | +0.51% |
| Volume | 26,452 | 202,040 | 77,200 | 281,738 | 484,881 |
| 20-Day Average Volume | 826,653 | 3,140,522 | 10,792,165 | 2,091,507 | 5,947,314 |
| Previous Close | 37.81 | 102.00 | 48.30 | 262.75 | 66.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.65 | 105.37 | 50.82 | 272.29 | 69.87 |
| 20-Day Raw Stochastic | 6.72% | 28.88% | 9.84% | 9.81% | 4.89% |
| 20-Day Relative Strength | 42.76% | 49.37% | 37.45% | 37.60% | 28.67% |
| Weighted Alpha | +7.77 | -19.27 | -30.18 | +4.66 | -25.06 |
| Today's Opinion | 8% Buy | 72% Buy | 72% Sell | 56% Sell | 100% Sell |
| Previous Opinion | 8% Sell | 72% Buy | 72% Sell | 56% Sell | 100% Sell |
| Last Month's Opinion | 24% Buy | 56% Buy | 24% Sell | 8% Sell | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.61% since 04/12/24 | -2.55% since 04/12/24 | +0.02% since 04/12/24 | -1.42% since 04/12/24 | -2.61% since 04/12/24 |
| Low | 37.73 on 04/19/24 | 99.90 on 04/18/24 | 47.62 on 04/18/24 | 260.75 on 04/19/24 | 65.90 on 04/18/24 |
| High | 39.27 on 04/15/24 | 106.42 on 04/16/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 |
| 1-Month | |||||
| %Chg | -6.91% since 03/19/24 | -2.53% since 03/19/24 | -6.78% since 03/19/24 | -3.04% since 03/19/24 | -9.70% since 03/19/24 |
| Low | 37.73 on 04/19/24 | 97.00 on 04/03/24 | 47.62 on 04/18/24 | 260.75 on 04/19/24 | 65.90 on 04/18/24 |
| High | 42.30 on 03/21/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | +11.24% since 01/19/24 | +2.76% since 01/19/24 | -3.63% since 01/19/24 | -14.40% since 01/19/24 | -24.06% since 01/19/24 |
| Low | 33.15 on 02/05/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 260.75 on 04/19/24 | 65.90 on 04/18/24 |
| High | 42.64 on 03/13/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +6.12% since 10/19/23 | +24.38% since 10/19/23 | -14.50% since 10/19/23 | -6.10% since 10/19/23 | -15.49% since 10/19/23 |
| Low | 32.83 on 10/25/23 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 |
| High | 42.82 on 12/14/23 | 115.97 on 01/08/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,803,912 | 39,053,760 | 97,892,464 | 140,812,720 | 82,374,304 |
| Shares Outstanding, K | 127,054 | 382,880 | 2,026,759 | 535,919 | 1,245,077 |
| Annual Sales | 829,250,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | 281,590,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 230,040,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | 85,390,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.25 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.82 on 02/20/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 14.91 | 0.00 | 6.38 | 14.16 | 9.96 |